Liftstream is an executive search recruitment company in the life sciences sector
Astellas joins with Harvard for Gene Therapy push
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged AAV, Astellas Innovation Management, Astellas Pharmaceutical, Biopolis, Boston Biotech, Constance Cepko, Gene therapy, Harvard, Japan, Malaysia Biotech, partnership, research and development, retinitis pigmentosa
Leave a comment
How can biotech enhance executive leadership?
Take our short survey and participate in a global gender diversity study
Working in biotech, pharma or venture capital?
Posted in Pharmaceutical business, Workplace Diversity
Tagged Amsterdam Biotech, Bay Area Cluster, BioCat, Biopolis, BioRN, biotech, bioValley, Board level, Boston Biotech, Cancer Bio-Sante, Diversity, Flanders Biotech, Global Diversity Survey 2014, leadership, London Biotech, Malaysia Biotech, Medicon Valley, men, Munich Biotech, New Zealand Biotech, One Nucleus, Oxford Biotech, pharma, pharmaceutical, Stevenage Biotech, women
Leave a comment
European biotech clusters must attract executive talent or seek new leaders
Authored by Karl Simpson
Posted in Job Hunting Advice, Pharmaceutical business
Tagged academics, Amsterdam Biotech, Bay Area Cluster, BioCat, Biopolis, BioRN, Biotech Clusters, biotechnology, bioValley, Boston Biotech, Bruce Booth, Cancer Bio-Sante, Chairman, commercial, development, Flanders Biotech, Industry, Katrine Bosley, London Biotech, Malaysia Biotech, Medical Devices, medical technology, Medicon Valley, Munich Biotech, New Zealand Biotech, non executive directors, One Nucleus, Oxford Biotech, pharmaceutical, research, Stevenage Biotech
Leave a comment
Biotech IPO fever spreads from West to East
Authored by Karl Simpson
Posted in M&A Finance and Funding, Pharmaceutical business
Tagged Ataluren, Biopolis, cardiomyocytes, derived neurons, DMD, Duchenne Muscular Dystrophy, Human iPSC, Institute of Medical Sciences, IPO, Japan, JASDAQ, Kyoto University, Malaysia Biotech, New Zealand Biotech, Prof. Hiromitsu Nakauchi, Prof. Norio Nakatsuji, PTC Therapeutics, ReproCELL, Stem Cell, University of Tokyo
Leave a comment